Literature DB >> 22801960

Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.

Elisabeth Salzer1, Svenja Daschkey, Sharon Choo, Michael Gombert, Elisangela Santos-Valente, Sebastian Ginzel, Martina Schwendinger, Oskar A Haas, Gerhard Fritsch, Winfried F Pickl, Elisabeth Förster-Waldl, Arndt Borkhardt, Kaan Boztug, Kirsten Bienemann, Markus G Seidel.   

Abstract

CD27, a tumor necrosis factor receptor family member, interacts with CD70 and influences T-, B- and NK-cell functions. Disturbance of this axis impairs immunity and memory generation against viruses including Epstein Barr virus (EBV), influenza, and others. CD27 is commonly used as marker of memory B cells for the classification of B-cell deficiencies including common variable immune deficiency. Flow cytometric immunophenotyping including expression analysis of CD27 on lymphoid cells was followed by capillary sequencing of CD27 in index patients, their parents, and non-affected siblings. More comprehensive genetic analysis employed single nucleotide polymorphism-based homozygosity mapping and whole exome sequencing. Analysis of exome sequencing data was performed at two centers using slightly different data analysis pipelines, each based on the Genome Analysis ToolKit Best Practice version 3 recommendations. A comprehensive clinical characterization was correlated to genotype. We report the simultaneous confirmation of human CD27 deficiency in 3 independent families (8 patients) due to a homozygous mutation (p. Cys53Tyr) revealed by whole exome sequencing, leading to disruption of an evolutionarily conserved cystein knot motif of the transmembrane receptor. Phenotypes varied from asymptomatic memory B-cell deficiency (n=3) to EBV-associated hemophagocytosis and lymphoproliferative disorder (LPD; n=3) and malignant lymphoma (n=2; +1 after LPD). Following EBV infection, hypogammaglobulinemia developed in at least 3 of the affected individuals, while specific anti-viral and anti-polysaccharide antibodies and EBV-specific T-cell responses were detectable. In severely affected patients, numbers of iNKT cells and NK-cell function were reduced. Two of 8 patients died, 2 others underwent allogeneic hematopoietic stem cell transplantation successfully, and one received anti-CD20 (rituximab) therapy repeatedly. Since homozygosity mapping and exome sequencing did not reveal additional modifying factors, our findings suggest that lack of functional CD27 predisposes towards a combined immunodeficiency associated with potentially fatal EBV-driven hemo-phagocytosis, lymphoproliferation, and lymphoma development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801960      PMCID: PMC3659923          DOI: 10.3324/haematol.2012.068791

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  34 in total

1.  CD27: a new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder?

Authors:  Markus G Seidel
Journal:  J Allergy Clin Immunol       Date:  2012-02-25       Impact factor: 10.793

2.  CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.

Authors:  Ana DeBarros; Miguel Chaves-Ferreira; Francisco d'Orey; Julie C Ribot; Bruno Silva-Santos
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

3.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.

Authors:  Abel González-Pérez; Nuria López-Bigas
Journal:  Am J Hum Genet       Date:  2011-03-31       Impact factor: 11.025

4.  CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo.

Authors:  De-Gang Song; Qunrui Ye; Mathilde Poussin; Gretchen M Harms; Mariangela Figini; Daniel J Powell
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

5.  Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.

Authors:  Zoya Kuzmina; Hildegard T Greinix; Roman Weigl; Ulrike Körmöczi; Arno Rottal; Sophie Frantal; Sandra Eder; Winfried F Pickl
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

Review 6.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.

Authors:  D Camerini; G Walz; W A Loenen; J Borst; B Seed
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  S152 (CD27). A modulating disulfide-linked T cell activation antigen.

Authors:  R D Bigler; Y Bushkin; N Chiorazzi
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

10.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

View more
  59 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.

Authors:  Il-Kyu Choi; Zhe Wang; Qiang Ke; Min Hong; Yu Qian; Xiujuan Zhao; Yuting Liu; Hye-Jung Kim; Jerome Ritz; Harvey Cantor; Klaus Rajewsky; Kai W Wucherpfennig; Baochun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

Review 3.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

Review 4.  Three-stage quality control strategies for DNA re-sequencing data.

Authors:  Yan Guo; Fei Ye; Quanghu Sheng; Travis Clark; David C Samuels
Journal:  Brief Bioinform       Date:  2013-09-24       Impact factor: 11.622

5.  A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services.

Authors:  Ghunwa Nakouzi; Khalil Kreidieh; Soha Yazbek
Journal:  J Community Genet       Date:  2014-09-27

Review 6.  The importance of co-stimulation in the orchestration of T helper cell differentiation.

Authors:  Jonathan M Coquet; Lisa Rausch; Jannie Borst
Journal:  Immunol Cell Biol       Date:  2015-04-21       Impact factor: 5.126

7.  Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24.

Authors:  Svenja Daschkey; Kirsten Bienemann; Volker Schuster; Hans Wolfgang Kreth; René Martin Linka; Andrea Hönscheid; Gerhard Fritz; Christian Johannes; Bernhard Fleckenstein; Bettina Kempkes; Michael Gombert; Sebastian Ginzel; Arndt Borkhardt
Journal:  J Clin Immunol       Date:  2016-07-29       Impact factor: 8.317

8.  Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency.

Authors:  M Elgizouli; D M Lowe; C Speckmann; D Schubert; J Hülsdünker; Z Eskandarian; A Dudek; A Schmitt-Graeff; J Wanders; S F Jørgensen; B Fevang; U Salzer; A Nieters; S Burns; B Grimbacher
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

Review 9.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

10.  B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Authors:  Elisabeth Salzer; Elisangela Santos-Valente; Stefanie Klaver; Sol A Ban; Wolfgang Emminger; Nina Kathrin Prengemann; Wojciech Garncarz; Leonhard Müllauer; Renate Kain; Heidrun Boztug; Andreas Heitger; Klaus Arbeiter; Franz Eitelberger; Markus G Seidel; Wolfgang Holter; Arnold Pollak; Winfried F Pickl; Elisabeth Förster-Waldl; Kaan Boztug
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.